Brazil

8 Vaccines Approved for Use in Brazil

RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
25 trials in 8 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Serum Institute of India

Covishield (Oxford/ AstraZeneca formulation)

Approved in 49 countries
6 trials in 1 country
Approval Source: bio.fiocruz.br
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries
Approval Source: gov.br
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
42 trials in 10 countries
Approval Source: apnews.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Approval Source: reuters.com

14 in Clinical Trials in Brazil

Protein Subunit

Clover

SCB-2019

15 trials in 13 countries
VLP

Medicago

Covifenz

Approved in 1 country
6 trials in 6 countries
DNA

Inovio

INO-4800

10 trials in 9 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

AZD2816

2 trials in 2 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Non Replicating Viral Vector

ReiThera

GRAd-COV2

5 trials in 12 countries
Inactivated

Chinese Academy of Medical Sciences

Inactivated (Vero Cells)

8 trials in 4 countries
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
42 trials in 10 countries
Non Replicating Viral Vector

Mahidol University

NDV-HXP-S

7 trials in 3 countries
Protein Subunit

University of Saskatchewan

COVAC-1

RNA

SENAI CIMATEC

HDT-301

2 trials in 1 country
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries

1 Vaccines with Trials in Brazil are No Longer Progressing

Non Replicating Viral Vector

Oxford/AstraZeneca

AZD2816

2 trials in 2 countries